Patrick L McGeer Selected Research

Aurintricarboxylic Acid

1/2014	Aurin tricarboxylic acid protects against red blood cell hemolysis in patients with paroxysmal nocturnal hemoglobinemia.
10/2012	Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic acid synthetic complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick L McGeer Research Topics

Disease

39	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 07/2002
21	Inflammation (Inflammations) 01/2018 - 04/2002
18	Parkinson Disease (Parkinson's Disease) 10/2016 - 06/2002
17	Neuroblastoma 03/2015 - 07/2002
12	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2016 - 03/2002
8	Neuroinflammatory Diseases 02/2016 - 07/2003
7	Amyloid Plaque 01/2018 - 05/2003
7	Dementia (Dementias) 07/2012 - 09/2003
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2015 - 12/2008
5	Astrocytoma (Pilocytic Astrocytoma) 09/2012 - 10/2006
4	Macular Degeneration (Age-Related Maculopathy) 10/2015 - 12/2005
3	Synucleinopathies 10/2016 - 05/2008
3	Parkinsonian Disorders (Parkinsonism) 07/2012 - 01/2006
3	Multiple Sclerosis 08/2004 - 03/2002
2	Neoplasms (Cancer) 01/2020 - 01/2011
2	Type 2 Diabetes Mellitus (MODY) 01/2016 - 09/2010
2	Hemolysis 10/2015 - 01/2014
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 04/2011 - 04/2010
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 08/2009 - 12/2008
2	Atherosclerosis 12/2004 - 07/2002
2	Myocardial Infarction 07/2002 - 07/2002
2	Demyelinating Diseases (Demyelinating Disease) 03/2002 - 01/2002
1	Coronary Disease (Coronary Heart Disease) 01/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Poisoning 02/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2016
1	Calciphylaxis 02/2016
1	Amyloidosis 01/2016
1	Bacterial Infections (Bacterial Infection) 01/2016
1	Persistent Infection 01/2016
1	Cognitive Dysfunction 01/2016
1	Vascular Remodeling 01/2013
1	Nervous System Diseases (Neurological Disorders) 01/2011
1	Brain Neoplasms (Brain Tumor) 01/2011
1	Glioma (Gliomas) 01/2011

Drug/Important Bio-Agent (IBA)

14	Complement System Proteins (Complement)IBA 01/2016 - 03/2002
12	Amyloid (Amyloid Fibrils)IBA 01/2018 - 07/2003
11	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2002
10	Amyloid beta-PeptidesIBA 01/2015 - 01/2002
8	alpha-SynucleinIBA 10/2016 - 10/2006
8	CytokinesIBA 03/2015 - 12/2002
7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2010 - 07/2002
6	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2016 - 07/2005
4	Interleukin-6 (Interleukin 6)IBA 01/2011 - 05/2004
4	Peptides (Polypeptides)IBA 01/2011 - 01/2002
4	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 03/2008 - 11/2003
4	Messenger RNA (mRNA)IBA 10/2006 - 06/2003
3	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 06/2015 - 05/2003
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2013 - 01/2010
3	Interferon-gamma (Interferon, gamma)IBA 01/2010 - 05/2009
3	Phosphotransferases (Kinase)IBA 09/2009 - 10/2006
3	Leucine (L-Leucine)FDA Link 09/2009 - 10/2006
3	UbiquitinIBA 12/2008 - 09/2007
3	AntibodiesIBA 12/2008 - 09/2003
2	Islet Amyloid PolypeptideIBA 01/2016 - 09/2010
2	ChemokinesIBA 03/2015 - 12/2002
2	Aurintricarboxylic AcidIBA 01/2014 - 10/2012
2	Chromogranin AIBA 12/2013 - 01/2002
2	InterferonsIBA 09/2012 - 07/2008
2	Omeprazole (Prilosec)FDA LinkGeneric 05/2011 - 05/2009
2	Lansoprazole (Prevacid)FDA LinkGeneric 05/2011 - 05/2009
2	Purinergic Receptors (Receptors, Purine)IBA 01/2011 - 01/2011
2	LigandsIBA 01/2011 - 08/2007
2	DNA-Binding Proteins (DNA Binding Protein)IBA 08/2009 - 12/2008
2	LipopolysaccharidesIBA 05/2009 - 07/2008
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2006 - 01/2006
2	Thrombin FDA Link 01/2006 - 02/2005
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2004 - 07/2002
1	Pharmaceutical PreparationsIBA 10/2016
1	Coffee FDA Link 10/2016
1	QuercetinIBA 10/2016
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 10/2016
1	Cyanides (Isocyanides)IBA 02/2016
1	sodium thiosulfate FDA Link 02/2016
1	Bexarotene (LGD1069)FDA Link 01/2016
1	amsonic acid (DAS)IBA 10/2015
1	Interleukin-18 (Interleukin 18)IBA 06/2015
1	InflammasomesIBA 06/2015
1	CathelicidinsIBA 03/2015
1	Interleukin-8 (Interleukin 8)IBA 03/2015
1	4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl 2-((4-(nitrooxy)butanoyl)oxy)benzoateIBA 10/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2013
1	Proto-Oncogene Protein c-ets-1IBA 01/2013
1	aurin quadracarboxylic acidIBA 10/2012
1	aurin hexacarboxylic acidIBA 10/2012
1	Verapamil (Calan)FDA LinkGeneric 09/2012
1	Nimodipine (Modus)FDA LinkGeneric 09/2012
1	Alanine (L-Alanine)FDA Link 07/2012
1	NeurotoxinsIBA 07/2012
1	Prion ProteinsIBA 04/2011
1	5'-methylthioadenosineIBA 02/2011
1	Pemetrexed (MTA)FDA Link 02/2011
1	NSC 74859IBA 02/2011
1	Janus Kinase InhibitorsIBA 02/2011
1	triphosphoric acid (triphosphate)IBA 01/2011
1	HLA-DR Antigens (HLA-DR)IBA 01/2011

Therapy/Procedure

5	Therapeutics 10/2013 - 11/2003
2	Immunotherapy 07/2004 - 02/2004
1	Renal Dialysis (Hemodialysis) 02/2016
1	Intravenous Administration 01/2011